(AXON) Axon Enterprise - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US05464C1018
Stock:
Total Rating 33
Risk 92
Buy Signal -0.62
| Risk 5d forecast | |
|---|---|
| Volatility | 60.9% |
| Relative Tail Risk | -21.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.05 |
| Alpha | -37.29 |
| Character TTM | |
|---|---|
| Beta | 1.642 |
| Beta Downside | 0.540 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.11% |
| CAGR/Max DD | 0.56 |
EPS (Earnings per Share)
Revenue
Primary Risks
P/E ratio: 138.717
Description: AXON Axon Enterprise
Axon Enterprise, Inc. provides public safety technology solutions in the United States and internationally. The company operates in two segments, Software and Sensors, and TASER. The Software and Sensors segment develops, manufactures, and sells integrated hardware and cloud-based software solutions that enable law enforcement to capture, store, manage, share, and analyze video and other digital evidence. This segment also offers body cameras, in-car cameras, other hardware sensors, warranties on sensors, and other products, as well as professional services. The TASER segment engages in the development, manufacture, and sale of conducted energy devices (CEDs) under the TASER brand; manufacture and sale of CEDs, batteries, accessories and extended warranties, digital subscription training content, and virtual reality (VR) training content, as well as other professional services related to TASER and VR deployments. The company serves first responders across international, federal, state, and local law enforcement; and fire, corrections, and emergency medical services, as well as justice sector, commercial enterprises, and consumers through online store, distribution partners, and third-party resellers. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 257.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -3.32 > 1.0 |
| NWC/Revenue: 112.1% < 20% (prev 83.11%; Δ 28.97% < -1%) |
| CFO/TA 0.04 > 3% & CFO 244.3m > Net Income 257.1m |
| Net Debt (678.2m) to EBITDA (310.9m): 2.18 < 3 |
| Current Ratio: 3.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.4m) vs 12m ago 0.43% < -2% |
| Gross Margin: 60.31% > 18% (prev 0.60%; Δ 5971 % > 0.5%) |
| Asset Turnover: 47.98% > 50% (prev 48.38%; Δ -0.40% > 0%) |
| Interest Coverage Ratio: 3.52 > 6 (EBITDA TTM 310.9m / Interest Expense TTM 67.2m) |
Altman Z'' 3.85
| A: 0.43 (Total Current Assets 4.22b - Total Current Liabilities 1.35b) / Total Assets 6.66b |
| B: 0.14 (Retained Earnings 933.9m / Total Assets 6.66b) |
| C: 0.04 (EBIT TTM 237.0m / Avg Total Assets 5.33b) |
| D: 0.25 (Book Value of Equity 921.4m / Total Liabilities 3.63b) |
| Altman-Z'' Score: 3.85 = AA |
Beneish M -3.15
| DSRI: 0.60 (Receivables 700.7m/885.6m, Revenue 2.56b/1.94b) |
| GMI: 0.99 (GM 60.31% / 59.84%) |
| AQI: 0.97 (AQ_t 0.32 / AQ_t-1 0.33) |
| SGI: 1.32 (Revenue 2.56b / 1.94b) |
| TATA: 0.00 (NI 257.1m - CFO 244.3m) / TA 6.66b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of AXON shares?
As of February 25, 2026, the stock is trading at USD 442.51 with a total of 1,395,922 shares traded.
Over the past week, the price has changed by +2.45%, over one month by -26.87%, over three months by -15.65% and over the past year by -11.45%.
Over the past week, the price has changed by +2.45%, over one month by -26.87%, over three months by -15.65% and over the past year by -11.45%.
Is AXON a buy, sell or hold?
Axon Enterprise has received a consensus analysts rating of 4.24.
Therefore, it is recommended to buy AXON.
- StrongBuy: 7
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AXON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 798.7 | 80.5% |
| Analysts Target Price | 798.7 | 80.5% |
AXON Fundamental Data Overview February 21, 2026
P/E Trailing = 138.717
P/E Forward = 54.6448
P/S = 13.699
P/B = 11.273
P/EG = 2.86
Revenue TTM = 2.56b USD
EBIT TTM = 237.0m USD
EBITDA TTM = 310.9m USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 279.6m USD (from shortTermDebt, last quarter)
Debt = 2.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 678.2m USD (from netDebt column, last quarter)
Enterprise Value = 34.77b USD (35.04b + Debt 2.10b - CCE 2.38b)
Interest Coverage Ratio = 3.52 (Ebit TTM 237.0m / Interest Expense TTM 67.2m)
EV/FCF = 239.7x (Enterprise Value 34.77b / FCF TTM 145.0m)
FCF Yield = 0.42% (FCF TTM 145.0m / Enterprise Value 34.77b)
FCF Margin = 5.67% (FCF TTM 145.0m / Revenue TTM 2.56b)
Net Margin = 10.05% (Net Income TTM 257.1m / Revenue TTM 2.56b)
Gross Margin = 60.31% ((Revenue TTM 2.56b - Cost of Revenue TTM 1.02b) / Revenue TTM)
Gross Margin QoQ = 60.14% (prev 60.39%)
Tobins Q-Ratio = 5.22 (Enterprise Value 34.77b / Total Assets 6.66b)
Interest Expense / Debt = 1.38% (Interest Expense 28.9m / Debt 2.10b)
Taxrate = 1.17% (4.47m / 381.5m)
NOPAT = 234.2m (EBIT 237.0m * (1 - 1.17%))
Current Ratio = 3.12 (Total Current Assets 4.22b / Total Current Liabilities 1.35b)
Debt / Equity = 0.69 (Debt 2.10b / totalStockholderEquity, last quarter 3.03b)
Debt / EBITDA = 2.18 (Net Debt 678.2m / EBITDA 310.9m)
Debt / FCF = 4.68 (Net Debt 678.2m / FCF TTM 145.0m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.82% (Net Income 257.1m / Total Assets 6.66b)
RoE = 9.66% (Net Income TTM 257.1m / Total Stockholder Equity 2.66b)
RoCE = 5.40% (EBIT 237.0m / Capital Employed (Equity 2.66b + L.T.Debt 1.73b))
RoIC = 5.40% (NOPAT 234.2m / Invested Capital 4.34b)
WACC = 11.37% (E(35.04b)/V(37.14b) * Re(11.97%) + D(2.10b)/V(37.14b) * Rd(1.38%) * (1-Tc(0.01)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.46%
[DCF] Terminal Value 71.11% ; FCFF base≈175.1m ; Y1≈216.0m ; Y5≈367.8m
[DCF] Fair Price = 37.63 (EV 3.67b - Net Debt 678.2m = Equity 2.99b / Shares 79.4m; r=11.37% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 39.00 | EPS CAGR: -35.02% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.32 | Revenue CAGR: 37.11% | SUE: 0.83 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.59 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=15
EPS next Year (2026-12-31): EPS=7.57 | Chg7d=+0.032 | Chg30d=+0.028 | Revisions Net=-1 | Growth EPS=+19.9% | Growth Revenue=+25.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.2% (Discount Rate 12.0% - Earnings Yield 0.7%)
[Growth] Growth Spread = +16.4% (Analyst 27.7% - Implied 11.2%)
P/E Forward = 54.6448
P/S = 13.699
P/B = 11.273
P/EG = 2.86
Revenue TTM = 2.56b USD
EBIT TTM = 237.0m USD
EBITDA TTM = 310.9m USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 279.6m USD (from shortTermDebt, last quarter)
Debt = 2.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 678.2m USD (from netDebt column, last quarter)
Enterprise Value = 34.77b USD (35.04b + Debt 2.10b - CCE 2.38b)
Interest Coverage Ratio = 3.52 (Ebit TTM 237.0m / Interest Expense TTM 67.2m)
EV/FCF = 239.7x (Enterprise Value 34.77b / FCF TTM 145.0m)
FCF Yield = 0.42% (FCF TTM 145.0m / Enterprise Value 34.77b)
FCF Margin = 5.67% (FCF TTM 145.0m / Revenue TTM 2.56b)
Net Margin = 10.05% (Net Income TTM 257.1m / Revenue TTM 2.56b)
Gross Margin = 60.31% ((Revenue TTM 2.56b - Cost of Revenue TTM 1.02b) / Revenue TTM)
Gross Margin QoQ = 60.14% (prev 60.39%)
Tobins Q-Ratio = 5.22 (Enterprise Value 34.77b / Total Assets 6.66b)
Interest Expense / Debt = 1.38% (Interest Expense 28.9m / Debt 2.10b)
Taxrate = 1.17% (4.47m / 381.5m)
NOPAT = 234.2m (EBIT 237.0m * (1 - 1.17%))
Current Ratio = 3.12 (Total Current Assets 4.22b / Total Current Liabilities 1.35b)
Debt / Equity = 0.69 (Debt 2.10b / totalStockholderEquity, last quarter 3.03b)
Debt / EBITDA = 2.18 (Net Debt 678.2m / EBITDA 310.9m)
Debt / FCF = 4.68 (Net Debt 678.2m / FCF TTM 145.0m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.82% (Net Income 257.1m / Total Assets 6.66b)
RoE = 9.66% (Net Income TTM 257.1m / Total Stockholder Equity 2.66b)
RoCE = 5.40% (EBIT 237.0m / Capital Employed (Equity 2.66b + L.T.Debt 1.73b))
RoIC = 5.40% (NOPAT 234.2m / Invested Capital 4.34b)
WACC = 11.37% (E(35.04b)/V(37.14b) * Re(11.97%) + D(2.10b)/V(37.14b) * Rd(1.38%) * (1-Tc(0.01)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.46%
[DCF] Terminal Value 71.11% ; FCFF base≈175.1m ; Y1≈216.0m ; Y5≈367.8m
[DCF] Fair Price = 37.63 (EV 3.67b - Net Debt 678.2m = Equity 2.99b / Shares 79.4m; r=11.37% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 39.00 | EPS CAGR: -35.02% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.32 | Revenue CAGR: 37.11% | SUE: 0.83 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.59 | Chg7d=+0.000 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=15
EPS next Year (2026-12-31): EPS=7.57 | Chg7d=+0.032 | Chg30d=+0.028 | Revisions Net=-1 | Growth EPS=+19.9% | Growth Revenue=+25.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.2% (Discount Rate 12.0% - Earnings Yield 0.7%)
[Growth] Growth Spread = +16.4% (Analyst 27.7% - Implied 11.2%)